ARTICLE | Distillery Therapeutics
Cancer
August 16, 2017 5:43 PM UTC
Mouse studies suggest inhibiting PTPN2 could help sensitize tumors to anti-PD-1 mAbs. In two mouse models of melanoma and a mouse model of colorectal cancer treated with an anti-PD-1 mAb, tumor-specif...
BCIQ Company Profiles
BCIQ Target Profiles
Protein tyrosine phosphatase non-receptor type 2 (PTPN2) (TC-PTP)